Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review
Authors:
- 5 February 2016
- journal article
- case report
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 12 (1) , 91-95
Abstract
Radiation lung injury usually develops 1–6 months after cessation of radiation therapy to the lung. Acute change in the previously irradiated lung after administration of antineoplastic agent is known as radiation recall pneumonitis. Erlotinib is a reversible epidemal growth factor receptor tyrosine kinase inhibitor, which is effective for patients with advanced lung cancer with epidermal growth factor receptor mutations. Here we report a rare case of radiation recall pneumonitis following treatment with erlotinib 4 months after palliative radiotherapy to the lung. A 76‐year‐old man with non–small cell lung cancer was treated with polychemotherapy, palliative thoracic irradiation (30 Gy in 12 fractions) and erlotinib thereafter. Two months after administration of erlotinib he developed of severe dyspnea, cough, anorexia and lack of energy. CT chest revealed extensive radiation pneumonitis. Erlotinib was ceased and high‐dose steroids were started. The symptoms ultimately resolved and erlotinib was resumed cautiously after 11 weeks. On dosimetric analysis, lung V20 and the mean lung dose were 20.33% and 10.7 Gy, respectively, and hence, the risk of radiation pneumonitis is very low. These data indicate that systemic administration of erlotinib after low‐dose palliative radiation therapy can be associated with unexpected toxicity when visceral organs are within the radiation field.Keywords
This publication has 25 references indexed in Scilit:
- Radiation Recall Pneumonitis Caused by Erlotinib after Palliative Definitive RadiotherapyOnkologie, 2012
- Radiation Recall Pneumonitis Induced by GemcitabineStrahlentherapie und Onkologie, 2007
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Challenges in defining radiation pneumonitis in patients with lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Effects of Radiation Therapy on the Lung: Radiologic Appearances and Differential DiagnosisRadioGraphics, 2004
- Side Effects of ChemotherapyJournal of Clinical Oncology, 2000
- Pulmonary Radiation InjuryChest, 1997
- The “recall effect” in radiotherapy: Is subeffective, reparable damage involved?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapyBritish Journal of Radiology, 1985
- Changes in Lung and Pleura Following Two-Million-Volt Therapy for Carcinoma of the BreastRadiology, 1957